2000
DOI: 10.1086/315577
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of Human Caliciviruses by Use of Enzyme Immunoassays

Abstract: The application of molecular technologies, such as the expression of viral proteins in baculovirus, has provided a powerful approach to the diagnosis of human calicivirus (HuCV) infections. The baculovirus-expressed HuCV capsid protein self-assembles into virus-like particles, providing excellent reagents for immunologic assays, such as enzyme immunoassays (EIAs). Following the expression of the capsid protein of Norwalk virus, the capsid proteins of 8 other HuCV strains have been expressed in baculovirus. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
50
1
2

Year Published

2000
2000
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 101 publications
(54 citation statements)
references
References 83 publications
1
50
1
2
Order By: Relevance
“…Moreover, it has been found, that existing NoV VLP antibodies do not block the immunization with another NoV VLP [43]. Therefore, despite the high level of pre-existing NoV antibodies [43,44], the use of NoV VLPs as a carrier might not be impaired by them. Applications for these engineered VLPs include the creation of novel vaccines presenting unique immunological content on their surface; steering or enhancing the immune response; targeting specific cells; and encapsidation or display of different molecules, from nucleotides, genes, peptides and proteins to therapeutic drugs and inorganic nanomaterials [13,45].…”
Section: Resultsmentioning
confidence: 99%
“…Moreover, it has been found, that existing NoV VLP antibodies do not block the immunization with another NoV VLP [43]. Therefore, despite the high level of pre-existing NoV antibodies [43,44], the use of NoV VLPs as a carrier might not be impaired by them. Applications for these engineered VLPs include the creation of novel vaccines presenting unique immunological content on their surface; steering or enhancing the immune response; targeting specific cells; and encapsidation or display of different molecules, from nucleotides, genes, peptides and proteins to therapeutic drugs and inorganic nanomaterials [13,45].…”
Section: Resultsmentioning
confidence: 99%
“…Enzyme-linked immunosorbent assay (ELISA) for measuring antibodies to NVs. The conditions for ELISAs to detect antibodies in serum specimens described in previous studies (16,23) were used with minor modifications here. Partially purified rNV capsid proteins (rNorwalk, rMxV, and rVA387) were used to coat 96-well microtiter plates at 0.25 g/ml in phosphate-buffered saline (PBS), and the plates were incubated at 4°C overnight.…”
Section: Methodsmentioning
confidence: 99%
“…(Putzker et al, 2000) Laboratory procedures for both rotavirus and astrovirus detection were performed according to manufacturer's instructions. Norovirus detection was performed using a previously described enzyme immunoassay (Jiang et al, 2000).…”
Section: Virologymentioning
confidence: 99%